These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29530850)

  • 1. Posaconazole-Induced Pseudohyperaldosteronism.
    Kuriakose K; Nesbitt WJ; Greene M; Harris B
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530850
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Thompson GR; Chang D; Wittenberg RR; McHardy I; Semrad A
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
    Beck KR; Telisman L; van Koppen CJ; Thompson GR; Odermatt A
    J Steroid Biochem Mol Biol; 2020 May; 199():105605. PubMed ID: 31982514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation.
    Hoffmann WJ; McHardy I; Thompson GR
    Mycoses; 2018 May; 61(5):337-339. PubMed ID: 29385285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels.
    Mahmood M; Abu Saleh O; Sohail MR
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167540
    [No Abstract]   [Full Text] [Related]  

  • 6. Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
    Inderbinen SG; Zogg M; Kley M; Smieško M; Odermatt A
    Toxicol Appl Pharmacol; 2021 Feb; 412():115387. PubMed ID: 33387577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory Hypokalemia from Syndrome of Apparent Mineralocorticoid Excess on Low-Dose Posaconazole.
    Wassermann T; Reimer EK; McKinnon M; Stock W
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661880
    [No Abstract]   [Full Text] [Related]  

  • 8. Low doses of liquorice can induce hypertension encephalopathy.
    Russo S; Mastropasqua M; Mosetti MA; Persegani C; Paggi A
    Am J Nephrol; 2000; 20(2):145-8. PubMed ID: 10773616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dangers of herbal teas: hypertension and weakness caused by liquorice-induced apparent mineralocorticoid excess.
    Pandher R; Puvanendran A; Diamond TH
    Med J Aust; 2020 Sep; 213(5):207-208.e1. PubMed ID: 32776334
    [No Abstract]   [Full Text] [Related]  

  • 10. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posaconazole-Induced Hypertension Due to Inhibition of 11
    Thompson GR; Beck KR; Patt M; Kratschmar DV; Odermatt A
    J Endocr Soc; 2019 Jul; 3(7):1361-1366. PubMed ID: 31286100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent mineralocorticoid excess.
    Funder JW
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):151-153. PubMed ID: 26956190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizic acid induced acquired apparent mineralocorticoid excess syndrome with a hyperadrenergic state: a case report.
    Szendrey J; Poindexter A; Braden G
    J Med Case Rep; 2024 Aug; 18(1):358. PubMed ID: 39107810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal liquorice lollies (liquorice abuse causing pseudohyperaldosteronism).
    Flores-Robles BJ; Sandoval AR; Dardon JD; Blas CA
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24051150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohyperaldosteronism, liquorice, and hypertension.
    Sontia B; Mooney J; Gaudet L; Touyz RM
    J Clin Hypertens (Greenwich); 2008 Feb; 10(2):153-7. PubMed ID: 18256580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage treatment of histoplasmosis with posaconazole.
    Restrepo A; Tobón A; Clark B; Graham DR; Corcoran G; Bradsher RW; Goldman M; Pankey G; Moore T; Negroni R; Graybill JR
    J Infect; 2007 Apr; 54(4):319-27. PubMed ID: 16824608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited forms of mineralocorticoid hypertension.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):633-45. PubMed ID: 26303089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.
    Ji HH; Tang XW; Zhang N; Huo BN; Liu Y; Song L; Jia YT
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0166821. PubMed ID: 34662186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.
    Gulhan B; Ünsal Y; Baltu D; Çelik Ertaş NB; Özdemir G; Utine E; Ozcan HN; Duzova A; Gönç N
    Blood Press Monit; 2022 Jun; 27(3):208-211. PubMed ID: 35044984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome.
    Stavropoulos K; Sotiriadis A; Patoulias D; Imprialos K; Dampali R; Athyros V; Dinas K
    Gynecol Endocrinol; 2018 Dec; 34(12):1019-1021. PubMed ID: 29933704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.